The decision was taken due to the fewer number of eligible patients amid increasing treatment options than when the study was first designed, Anna Truppel-Hartmann, chief medical officer of 2seventy ...
GLP-1 agonists, widely used for obesity and diabetes management, have been associated with a reduced risk of most ...
The "Global Drug API Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global drug API market is projected to reach US$309.642 billion in 2029 from ...